+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Aspirin Market by Product, Packaging, Dosage Form, Dosage, Distribution Channel, End Users - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6013925
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Aspirin Market grew from USD 2.49 billion in 2023 to USD 2.58 billion in 2024. It is expected to continue growing at a CAGR of 4.62%, reaching USD 3.42 billion by 2030.

Aspirin, a widely used nonsteroidal anti-inflammatory drug (NSAID), serves a crucial role in healthcare for its analgesic, antipyretic, and anti-inflammatory properties. It is most prevalently used for pain relief, reducing fever, and mitigating inflammation, making it indispensable for both personal and medical applications. The pharmaceutical industry predominantly drives its application scope, alongside a growing utilization in cardiovascular treatments to prevent heart attacks and strokes due to its blood-thinning abilities. The versatility of aspirin extends to end-use markets like healthcare facilities, homes, and OTC retail sectors, providing various consumer and therapeutic benefits.

Market growth for aspirin is poised by several key factors, including the rising global geriatric population, increasing prevalence of chronic diseases, and expanding awareness of aspirin's preventive cardiovascular benefits. Notably, the latest potential opportunity arises from further research into aspirin's anticancer properties and its possible application in managing dementia, opening new therapeutic avenues. Companies can capitalize on these opportunities by investing in R&D and forming strategic partnerships with academic and medical institutions. However, market limitations such as gastrointestinal side effects and increased risk of bleeding challenge aspirin's broader acceptance. Regulatory constraints and the emergence of alternative medications further complicate its market dynamics.

Innovation in aspirin can focus on improving formulation to mitigate side effects, exploring new drug delivery systems like sustained-release tablets, and enhancing its therapeutic breadth through combination therapies. The nature of the aspirin market is relatively mature but remains dynamic due to ongoing research and emerging healthcare trends. Companies aiming for business growth should prioritize advancements in product lines and engage in educational campaigns to boost consumer confidence and demand. Thus, while the classical applications of aspirin are well established, continuous innovation and strategic market positioning are paramount for tapping into unexploited market potential and ensuring sustained growth.

Understanding Market Dynamics in the Aspirin Market

The Aspirin Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing prevalence of cardiovascular diseases
    • Expanding applications of aspirin for cancer prevention and treatment of inflammatory conditions
    • Rise in aging population susceptible to chronic diseases
  • Market Restraints
    • Availability of Alternative Medications with improved efficacy and fewer side effects
  • Market Opportunities
    • Investment in R&D for enhanced formulations of aspirin
    • Burgeoning growth in online platforms and telemedicine
  • Market Challenges
    • Stringent regulatory requirements for the approval of new formulations and applications of aspirin

Exploring Porter’s Five Forces for the Aspirin Market

Porter’s Five Forces framework further strengthens the insights of the Aspirin Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Aspirin Market

External macro-environmental factors deeply influence the performance of the Aspirin Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Aspirin Market

The Aspirin Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Aspirin Market

The Aspirin Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Aspirin Market

The Aspirin Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Aspirin Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Anhui Chemical Group Co., Ltd., Bayer AG, Bristol-Myers Squibb Company, China Meheco Topfond Pharma Co., Ltd., Cigna Corporation, Divi’s Laboratories Limited, Dow Chemical Company, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline PLC, Globe Química S.A., Granules India Limited, Hebei Jiheng (Group) Pharmaceutical Co., Ltd., Hubei Biocause Heilen Pharmaceutical Co., Ltd., Jiangsu Nanjing Huaxing Chemical Co., Ltd., Jiangsu Pioneer Pharma Co., Ltd., Lupin Pharmaceuticals, Inc., Merck & Co., Inc., Mylan N.V., Nanjing Well Pharmaceutical Technology Co., Ltd., Pfizer Inc., Sanofi S.A., SEQENS SAS, Shandong Xinhua Pharmaceutical Co., Ltd., Sun Pharmaceutical Industries Ltd., Taj Pharmaceuticals Ltd., and Zhenjiang Gaopeng Pharmaceutical Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Aspirin Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Buffered Aspirin
    • Enteric-Coated Aspirin
    • Regular Aspirin
  • Packaging
    • Blister Packs
    • Bottles
    • Sachets
  • Dosage Form
    • Capsules
    • Gels
    • Powders
    • Tablets
  • Dosage
    • High-Dose
    • Low-Dose
    • Medium-Dose
  • Distribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • End Users
    • Clinics
    • Home Care
    • Hospitals
    • Pharmaceutical Companies
    • Research Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of cardiovascular diseases
5.1.1.2. Expanding applications of aspirin for cancer prevention and treatment of inflammatory conditions
5.1.1.3. Rise in aging population susceptible to chronic diseases
5.1.2. Restraints
5.1.2.1. Availability of Alternative Medications with improved efficacy and fewer side effects
5.1.3. Opportunities
5.1.3.1. Investment in R&D for enhanced formulations of aspirin
5.1.3.2. Burgeoning growth in online platforms and telemedicine
5.1.4. Challenges
5.1.4.1. Stringent regulatory requirements for the approval of new formulations and applications of aspirin
5.2. Market Segmentation Analysis
5.2.1. Product: Increasing utilization of regular aspirin owing to its pain-relieving and anti-inflammatory properties
5.2.2. End Users: Evolving utilization of aspirin across the clinics owing to its broad availability
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Aspirin Market, by Product
6.1. Introduction
6.2. Buffered Aspirin
6.3. Enteric-Coated Aspirin
6.4. Regular Aspirin
7. Aspirin Market, by Packaging
7.1. Introduction
7.2. Blister Packs
7.3. Bottles
7.4. Sachets
8. Aspirin Market, by Dosage Form
8.1. Introduction
8.2. Capsules
8.3. Gels
8.4. Powders
8.5. Tablets
9. Aspirin Market, by Dosage
9.1. Introduction
9.2. High-Dose
9.3. Low-Dose
9.4. Medium-Dose
10. Aspirin Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.4. Retail Pharmacies
11. Aspirin Market, by End Users
11.1. Introduction
11.2. Clinics
11.3. Home Care
11.4. Hospitals
11.5. Pharmaceutical Companies
11.6. Research Institutes
12. Americas Aspirin Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Aspirin Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Aspirin Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2023
15.2. FPNV Positioning Matrix, 2023
15.3. Competitive Scenario Analysis
15.3.1. PEARLS trial, funded by Bill and Melinda Gates Foundation, explores optimal aspirin doses to prevent pre-eclampsia, collaborating with global institutions and utilizing AI tools
15.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. ASPIRIN MARKET RESEARCH PROCESS
FIGURE 2. ASPIRIN MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ASPIRIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ASPIRIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ASPIRIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ASPIRIN MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL ASPIRIN MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL ASPIRIN MARKET SIZE, BY PACKAGING, 2023 VS 2030 (%)
FIGURE 9. GLOBAL ASPIRIN MARKET SIZE, BY PACKAGING, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2023 VS 2030 (%)
FIGURE 11. GLOBAL ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL ASPIRIN MARKET SIZE, BY DOSAGE, 2023 VS 2030 (%)
FIGURE 13. GLOBAL ASPIRIN MARKET SIZE, BY DOSAGE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 15. GLOBAL ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL ASPIRIN MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
FIGURE 17. GLOBAL ASPIRIN MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. AMERICAS ASPIRIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. AMERICAS ASPIRIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. UNITED STATES ASPIRIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 21. UNITED STATES ASPIRIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. ASIA-PACIFIC ASPIRIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. ASIA-PACIFIC ASPIRIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ASPIRIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA ASPIRIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 26. ASPIRIN MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 27. ASPIRIN MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. ASPIRIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ASPIRIN MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ASPIRIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ASPIRIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. ASPIRIN MARKET DYNAMICS
TABLE 7. GLOBAL ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ASPIRIN MARKET SIZE, BY BUFFERED ASPIRIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ASPIRIN MARKET SIZE, BY ENTERIC-COATED ASPIRIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ASPIRIN MARKET SIZE, BY REGULAR ASPIRIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ASPIRIN MARKET SIZE, BY BLISTER PACKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ASPIRIN MARKET SIZE, BY BOTTLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ASPIRIN MARKET SIZE, BY SACHETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ASPIRIN MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ASPIRIN MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ASPIRIN MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ASPIRIN MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ASPIRIN MARKET SIZE, BY HIGH-DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ASPIRIN MARKET SIZE, BY LOW-DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ASPIRIN MARKET SIZE, BY MEDIUM-DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ASPIRIN MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ASPIRIN MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ASPIRIN MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ASPIRIN MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ASPIRIN MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ASPIRIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ASPIRIN MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ASPIRIN MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS ASPIRIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 53. CANADA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. CANADA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 55. CANADA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 56. CANADA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 57. CANADA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. CANADA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 59. MEXICO ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. MEXICO ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 61. MEXICO ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 62. MEXICO ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 63. MEXICO ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. MEXICO ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES ASPIRIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC ASPIRIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 79. AUSTRALIA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. AUSTRALIA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 81. AUSTRALIA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 82. AUSTRALIA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 83. AUSTRALIA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. AUSTRALIA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 85. CHINA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. CHINA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 87. CHINA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 88. CHINA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 89. CHINA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. CHINA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 91. INDIA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. INDIA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 93. INDIA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 94. INDIA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 95. INDIA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. INDIA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. INDONESIA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 99. INDONESIA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 100. INDONESIA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 101. INDONESIA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. INDONESIA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 103. JAPAN ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. JAPAN ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 105. JAPAN ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 106. JAPAN ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 107. JAPAN ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. JAPAN ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. MALAYSIA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 111. MALAYSIA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 112. MALAYSIA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 113. MALAYSIA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. MALAYSIA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. PHILIPPINES ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 117. PHILIPPINES ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 118. PHILIPPINES ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 119. PHILIPPINES ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. PHILIPPINES ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 121. SINGAPORE ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. SINGAPORE ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 123. SINGAPORE ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 124. SINGAPORE ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 125. SINGAPORE ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. SINGAPORE ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 127. SOUTH KOREA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. SOUTH KOREA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 129. SOUTH KOREA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 130. SOUTH KOREA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 131. SOUTH KOREA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. SOUTH KOREA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 133. TAIWAN ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. TAIWAN ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 135. TAIWAN ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 136. TAIWAN ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 137. TAIWAN ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. TAIWAN ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 139. THAILAND ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. THAILAND ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 141. THAILAND ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 142. THAILAND ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 143. THAILAND ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. THAILAND ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 145. VIETNAM ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. VIETNAM ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 147. VIETNAM ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 148. VIETNAM ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 149. VIETNAM ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. VIETNAM ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA ASPIRIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 158. DENMARK ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 159. DENMARK ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 160. DENMARK ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 161. DENMARK ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 162. DENMARK ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. DENMARK ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 164. EGYPT ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. EGYPT ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 166. EGYPT ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 167. EGYPT ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 168. EGYPT ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 169. EGYPT ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 170. FINLAND ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. FINLAND ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 172. FINLAND ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 173. FINLAND ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 174. FINLAND ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. FINLAND ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 176. FRANCE ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 177. FRANCE ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 178. FRANCE ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 179. FRANCE ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 180. FRANCE ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. FRANCE ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 182. GERMANY ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. GERMANY ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 184. GERMANY ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 185. GERMANY ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 186. GERMANY ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. GERMANY ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 188. ISRAEL ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 189. ISRAEL ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 190. ISRAEL ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 191. ISRAEL ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 192. ISRAEL ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. ISRAEL ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 194. ITALY ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 195. ITALY ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 196. ITALY ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 197. ITALY ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 198. ITALY ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 199. ITALY ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 212. NORWAY ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 213. NORWAY ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 214. NORWAY ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 215. NORWAY ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 216. NORWAY ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. NORWAY ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 218. POLAND ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 219. POLAND ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 220. POLAND ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 221. POLAND ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 222. POLAND ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 223. POLAND ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 224. QATAR ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 225. QATAR ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 226. QATAR ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 227. QATAR ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 228. QATAR ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. QATAR ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 235. RUSSIA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 248. SPAIN ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 249. SPAIN ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 250. SPAIN ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 251. SPAIN ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 252. SPAIN ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 253. SPAIN ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 258. SWEDEN ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 259. SWEDEN ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 266. TURKEY ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 267. TURKEY ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 268. TURKEY ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 269. TURKEY ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 270. TURKEY ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 271. TURKEY ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM ASPIRIN MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM ASPIRIN MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 280. UNITED KINGDOM ASPIRIN MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM ASPIRIN MARKET SIZE, BY DOSAGE, 2018-2030 (USD MILLION)
TABLE 282. UNITED KINGDOM ASPIRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM ASPIRIN MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 284. ASPIRIN MARKET SHARE, BY KEY PLAYER, 2023
TABLE 285. ASPIRIN MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Aspirin market, which are profiled in this report, include:
  • Abbott Laboratories
  • Anhui Chemical Group Co., Ltd.
  • Bayer AG
  • Bristol-Myers Squibb Company
  • China Meheco Topfond Pharma Co., Ltd.
  • Cigna Corporation
  • Divi’s Laboratories Limited
  • Dow Chemical Company
  • Dr. Reddy's Laboratories Ltd.
  • GlaxoSmithKline PLC
  • Globe Química S.A.
  • Granules India Limited
  • Hebei Jiheng (Group) Pharmaceutical Co., Ltd.
  • Hubei Biocause Heilen Pharmaceutical Co., Ltd.
  • Jiangsu Nanjing Huaxing Chemical Co., Ltd.
  • Jiangsu Pioneer Pharma Co., Ltd.
  • Lupin Pharmaceuticals, Inc.
  • Merck & Co., Inc.
  • Mylan N.V.
  • Nanjing Well Pharmaceutical Technology Co., Ltd.
  • Pfizer Inc.
  • Sanofi S.A.
  • SEQENS SAS
  • Shandong Xinhua Pharmaceutical Co., Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Taj Pharmaceuticals Ltd.
  • Zhenjiang Gaopeng Pharmaceutical Co., Ltd.

Methodology

Loading
LOADING...

Table Information